Condition
Parkinson-Dementia Syndrome
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
Early P 1 (1)
Trial Status
Completed1
Recruiting1
Enrolling By Invitation1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04148326Withdrawn
A Pilot Study to Explore the Role of Gut Flora in Parkinson's Disease
NCT03174938Not ApplicableRecruiting
The Swedish BioFINDER 2 Study
NCT03724136Not ApplicableEnrolling By Invitation
Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
NCT02243982Early Phase 1Completed
Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's Disease
Showing all 4 trials